Surgical capacity and need for follow-up remain barriers to broader access
Specifically, the FDA has not approved Ozempic for weight loss, but those with Type 2 Diabetes that use this drug, tend to slim down
Weight-loss meds offer a new way to stop cravings and shed pounds The Food and Drug Administration in 2021 approved semaglutide, the active ingredient in Ozempic, as a weight-management treatment
This distinguishes it from oral medications, where fibre can sometimes bind to drug molecules or alter absorption rates
Additional analyses demonstrated that oral semaglutide 7 mg was associated with improvements of 0.11 QALYs and increased costs of EUR 226 versus sitagliptin and was therefore associated with an ICER of EUR 2011 per QALY gained
Suddenly, the question isnt whether the medication works, but whether its financially realistic